Literature DB >> 34860523

Buchwald-Hartwig Amination of Aryl Halides with Heterocyclic Amines in the Synthesis of Highly Fluorescent Benzodifuran-Based Star-Shaped Organic Semiconductors.

Mariusz J Bosiak1,2, Alicja A Zielińska3,2, Piotr Trzaska1,2, Dariusz Kędziera4, Jörg Adams5.   

Abstract

The study of palladium-catalyzed amination of bromobenzene with aromatic and heterocyclic amines, widely used in the synthesis of organic semiconductors, was performed. The best conditions for the coupling of aryl bromides with carbazole, diphenylamine, phenoxazine, phenothiazine, 9,9-dimethyl-9,10-dihydroacridine, and their derivatives have been developed. Based on the results, nine new star-shaped organic semiconductors, exhibiting up to 100% fluorescent quantum yield in the 400-550 nm range, have been synthesized in good yields. The TDDFT calculations of the absorption spectra revealed a good correlation with experimental results and slight solvatochromic effects with a change in the polarity of the solvent.

Entities:  

Year:  2021        PMID: 34860523      PMCID: PMC8689646          DOI: 10.1021/acs.joc.1c01583

Source DB:  PubMed          Journal:  J Org Chem        ISSN: 0022-3263            Impact factor:   4.354


Introduction

Benzodifurans (BDFs), due to their p-type organic semiconductor properties, excellent light absorption and emission capability, and high hole mobility, are a group of compounds with a great potential application as luminescent and electroluminescent materials.[1−4] In addition, they are much less studied compared to benzodithiophenes widely used in optoelectronics. The appropriate molecular design of the BDF-based semiconductors allows for their application in many fields, including molecular switches and electrical regulators,[5−7] high-affinity fluorescent probes,[8] potential therapeutic agents,[9] dye-sensitized solar cell sensitizers,[10−13] polymer materials in polymer solar cells,[14−22] organic solar cells,[23,24] organic thin-film transistor materials,[25,26] and different layers in organic light-emitting diodes (LEDs).[27−34] A huge number of organic semiconductors used in optoelectronics as electron transport layers (ETL) and electron injection layers (EIL),[35,36] hole transport layers (HTL) and hole injection layers (HIL),[37,38] hosts for phosphorescent and thermally activated delayed fluorescent (TADF) materials,[39−43] and TADF materials themselves[44−51] contain aromatic or heterocyclic amines such as carbazole (Cz), diphenylamine (DPA), phenoxazine (PXZ), phenothiazine (PTZ), and 9,9-dimethyl-9,10-dihydroacridine (DMAC). Although in the literature one can find numerous examples of coupling of the above-mentioned amines and their derivatives,[52−54] the comprehensive study of their palladium-catalyzed coupling with aryl halides has not yet been performed. Herein, the study of the Buchwald–Hartwig amination of aryl bromides with the amines mentioned above, leading to novel star-shaped BDF derivatives, along with their density functional theory (DFT) and spectral characteristics, is described.

Results and Discussion

The benzodifuran core (TBBDF), containing four para-bromophenylene groups and long alkyl chains in positions 4 and 8 of the BDF core, to improve the solubility of the desired compounds, was synthesized according to the procedure described earlier by our team[55] and directed to the Buchwald–Hartwig amination with Cz, DPA, PXZ, PTZ, DMAC, and their derivatives (Scheme ).
Scheme 1

Buchwald–Hartwig Coupling Leading to Star-Shaped BDFs

Optimization of the Reaction Conditions

For the efficient synthesis of the expanded star-shaped systems by the Buchwald–Hartwig amination, the coupling conditions for each secondary amine with less-demanding bromobenzene were developed. The screening tests included selecting the palladium precatalyst, phosphine ligand, solvent, and base for the reaction.

Catalysts

To identify the best catalytic system, commercially available palladium catalysts and phosphine ligands were tested (Table ). It was found that Pd(dppf)Cl2, Pd(PPh3)2Cl2, and Pd(PPh3)2(OAc)2 (entries 19–21) were ineffective in Cz coupling, but they gave average results for DPA and DMAC and good conversion levels for PXZ and PTZ. For [Pd]/phosphine catalytic systems, we decided to use [Pd(allyl)Cl]2 dimer as a palladium source, although the Pd2(dba)3 precatalyst gave comparable results (entries 6 and 7) when sodium tert-butanolate in toluene and XPhos as a ligand were used. It was found that phosphines containing electron-donating groups on the biphenyl moiety gave poor conversion rates in the Cz and DPA coupling and the average for the other tested amines (entries 16 and 17). The best results for Cz coupling were obtained using TrixiePhos and t-BuBrettPhos (97%, entries 12 and 14, respectively). For DPA, it was [t-Bu3PH]BF4, XPhos, RuPhos, and SPhos (96%, entries 2, 6, 9, and 10). PXZ was found to be very easily coupled with bromobenzene, and results of >99% were obtained for eight ligands (entries 4–10, 12, and 13). The best conversion rates for PTZ coupling were obtained using DavePhos and XPhos (99%, entries 4 and 6) and for DMAC—t-BuXPhos (98%) and XPhos (96%) (entries 8 and 6). The most universal ligands were revealed to be XPhos and TrixiePhos, giving conversion rates above 90% for all tested amines.
Table 1

Coupling of Bromobenzene with Secondary Aryl Amines in the Presence of Commercially Available Phosphines and Palladium Catalysts

  conversion [%]d
entryconditionsaCzDPAPXZPTZDMAC
1PPh3075919053
2[(t-Bu)3PH]BF41396979592
3JohnPhos8989959590
4DavePhos8594>999987
5CyJohnPhos8685>999293
6XPhos9296>999996
7XPhosb8993>999988
8t-BuXPhos9487>999598
9RuPhos2996>999089
10SPhos5796>999778
11XantPhos4293958888
12TrixiePhos9791>999794
13t-BuDavePhos8892>999684
14t-BuBrettPhos9736947863
15P(o-tolyl)3089998081
16Me4t-BuXPhos2726955759
17Me3(OMe)t-BuXPhos1743857872
18(R/S)-BINAP48486119
19Pd(dppf)Cl2c263898258
20Pd(PPh3)2Cl2c071958965
21Pd(PPh3)2(OAc)2c238828743

[Pd(allyl)Cl]2 (1 mol %) and phosphine ligand (4 mol %).

Pd2(dba)3 instead of [Pd(allyl)Cl]2.

Catalyst (2 mol %).

GC–MS, average of two runs.

[Pd(allyl)Cl]2 (1 mol %) and phosphine ligand (4 mol %). Pd2(dba)3 instead of [Pd(allyl)Cl]2. Catalyst (2 mol %). GC–MS, average of two runs.

Solvent Screening

Using predetermined [Pd(allyl)Cl]2/ligand systems for each examined amine, the screening of solvent (Table ) and base type (Table ) was carried out. It was found that toluene was the best choice for all tested systems, allowing us to obtain over 95% conversion rates. Satisfactory good results were also obtained when 1,4-dioxane was used.
Table 2

Solvent Screening for the Coupling of Bromobenzene with Secondary Amines

 conversion [%]a
solventCzbDPAcPXZcPTZcDMACd
toluene9796>999998
1,4-dioxane8791>999893
THF8367838472
DMF283601935
DMSO21119126

GC–MS, average of two runs.

[Pd(allyl)Cl]2 (1 mol %) and TrixiePhos (4 mol %).

[Pd(allyl)Cl]2 (1 mol %) and XPhos (4 mol %).

[Pd(allyl)Cl]2 (1 mol %) and t-BuXPhos (4 mol %).

Table 3

Base Screening for the Coupling of Bromobenzene with Secondary Amines

 conversion [%]a
baseCzbDPAcPXZcPTZcDMACd
t-BuONa9796>999998
t-BuOLi9883898993
K2CO38235865564
K3PO44229855438
MeMgCl9592909389
Cs2CO39693>997788
KOH7767877982

GC–MS, average of two runs.

[Pd(allyl)Cl]2 (1 mol %) and TrixiePhos (4 mol %).

[Pd(allyl)Cl]2 (1 mol %) and XPhos (4 mol %).

[Pd(allyl)Cl]2 (1 mol %) and t-BuXPhos (4 mol %).

GC–MS, average of two runs. [Pd(allyl)Cl]2 (1 mol %) and TrixiePhos (4 mol %). [Pd(allyl)Cl]2 (1 mol %) and XPhos (4 mol %). [Pd(allyl)Cl]2 (1 mol %) and t-BuXPhos (4 mol %). GC–MS, average of two runs. [Pd(allyl)Cl]2 (1 mol %) and TrixiePhos (4 mol %). [Pd(allyl)Cl]2 (1 mol %) and XPhos (4 mol %). [Pd(allyl)Cl]2 (1 mol %) and t-BuXPhos (4 mol %).

Base Screening

The best base for the reaction with Cz proved to be t-BuOLi (98%), but almost equal yields were obtained for t-BuONa and Cs2CO3 (97 and 96%, respectively). t-BuONa seems to be the most universal, although t-BuOLi and Cs2CO3 also gave satisfactory results in individual cases (Table ). Good results were also obtained using methylmagnesium chloride as a base. Weaker inorganic bases (K2CO3, K3PO4, and KOH) gave good results only for coupling with PXZ, but the amination with this amine is relatively easy.

General Conditions

It was found that the Buchwald–Hartwig amination of bromobenzene with secondary amines is most preferably carried out in an environment of relatively non-polar solvents, although the base choice seems to be more complex; however, one can conclude that strong organic bases and Cs2CO3 will work well in this reaction. The best reaction systems for palladium-catalyzed coupling of bromobenzene with Cz proved to be TrixiePhos/t-BuOLi/toluene, with DPA, PXZ, and PTX—XPhos/t-BuONa/toluene, and with DMAC—t-BuXPhos/t-BuONa/toluene.

Star-Shaped BDF Synthesis

The developed conditions were applied to the synthesis of the fluorescent BDF star-shaped compounds. Amine 1b was commercially available (Table ), while the more complex amines (1a, 1c, and 1d) were synthesized according to the procedures presented in Scheme .
Table 4

Palladium-Catalyzed Coupling Reaction of TBBDF with Amines

[Pd(allyl)Cl]2 (8 mol %) and t-BuXPhos (32 mol %).

Pd(allyl)Cl]2 (8 mol %), t-BuXPhos (32 mol %), and base t-BuOLi instead of t-BuONa.

[Pd(allyl)Cl]2 (8 mol %), t-BuXPhos (32 mol %), and 170 °C in a sealed tube.

Scheme 2

Synthesis of Cz Derivatives Substituted in Positions 3 and 6

Conditions: aPd(dppf)Cl2 (1.35 mol %), CuI (2.7 mol %), i-Pr2NH (4 equiv), 1-decyne (2.5 equiv), toluene, 70 °C, and 3 h; bPd/C (10% w/w), hydrogen, 1 atm, ethyl acetate, 50 °C, and 12 h; c[Pd(allyl)Cl]2 (1 mol %), t-BuXPhos (4 mol %), Cz (2.1 equiv), t-BuOLi (2.1 equiv), 1,4-dioxane, 100 °C, and 24 h; dKOH (12 equiv), THF, DMSO, water, reflux, and 18 h; ePd2(dba)3 (2 mol %), XPhos (8 mol %), DPA (2.08 equiv), t-BuONa (2.08 equiv), toluene, 100 °C, and 24 h; and fDCM, trifluoroacetic acid (10 equiv), RT, and 2.5 h.

Synthesis of Cz Derivatives Substituted in Positions 3 and 6

Conditions: aPd(dppf)Cl2 (1.35 mol %), CuI (2.7 mol %), i-Pr2NH (4 equiv), 1-decyne (2.5 equiv), toluene, 70 °C, and 3 h; bPd/C (10% w/w), hydrogen, 1 atm, ethyl acetate, 50 °C, and 12 h; c[Pd(allyl)Cl]2 (1 mol %), t-BuXPhos (4 mol %), Cz (2.1 equiv), t-BuOLi (2.1 equiv), 1,4-dioxane, 100 °C, and 24 h; dKOH (12 equiv), THF, DMSO, water, reflux, and 18 h; ePd2(dba)3 (2 mol %), XPhos (8 mol %), DPA (2.08 equiv), t-BuONa (2.08 equiv), toluene, 100 °C, and 24 h; and fDCM, trifluoroacetic acid (10 equiv), RT, and 2.5 h. [Pd(allyl)Cl]2 (8 mol %) and t-BuXPhos (32 mol %). Pd(allyl)Cl]2 (8 mol %), t-BuXPhos (32 mol %), and base t-BuOLi instead of t-BuONa. [Pd(allyl)Cl]2 (8 mol %), t-BuXPhos (32 mol %), and 170 °C in a sealed tube. For 1a synthesis, the Sonogashira reaction of DICz and 1-decyne, followed by hydrogen–Pd/C reduction, was performed. Amine 1c was obtained by the Buchwald–Hartwig reaction between DITosCz and Cz, followed by basic hydrolysis of the tosyl group. Although the Ullmann synthesis of 1c is described in the literature, our method allowed us to obtain the product in 68% yield using milder conditions (100 °C, 24 h vs 166 °C, and 48 h).[56] It was found that due to the better reactivity of aryl iodides compared to bromides, the same product yield was obtained after catalyst loading reduction to 0.5 mol % of [Pd(allyl)Cl]2 and 2 mol % of t-BuXPhos per one iodine atom. Compound 1d was synthesized analogously to 1c, but the use of the tert-butylcarboxycarbonate (Boc) protecting group was necessary since the reaction of DITosCz and standard [Pd(allyl)Cl]2/XPhos or Pd2(dba)3/[t-Bu3PH]BF4 catalytic systems led to the deiodination of DITosCz, resulting in a complex mixture of byproducts. The synthesis of 1d from DBBocCz was also described in the literature;[57] however, we found that temperature reduction from the literature 220 to 100 °C did not affect the yield of the reaction, which in both cases was 79%, but eliminates difficult to remove byproducts formed in the higher temperature. Based on the developed amination conditions, it was found that TBBDF coupling with Cz, DPA, PXZ, and PTZ (Table , entries 1–4) undergoes smoothly, yielding desired products in good yields (61–92%), and only for DMAC, the yield was significantly lower (19%, entry 5). Since TBBDF contains four bromophenylene moieties, the total catalyst loading was 4 mol % of [Pd(allyl)Cl]2 and 16 mol % of phosphine ligand. Larger loadings (8 and 32 mol %, respectively) were necessary to achieve satisfactory yields of 2f–2i (entries 6–9). Also, the ligand of choice for the more sterically demanding amines proved to be t-BuXPhos and t-BuONa as a base, and only for 2h (entry 8), t-BuOLi gave better results. Additionally, the increase of amine and base load to 1.5 equiv per one bromophenylene moiety allowed us to obtain slightly better results. Even in these conditions, the low yield was obtained for DMAC coupling due to the significant amounts of partially substituted and debrominated byproducts, and in this particular case, other catalytic systems should be considered. Another approach that worked well for coupling 1d with TBBDF was using a pressure vessel and temperature above the boiling point of toluene (entry 9). Thus, it was possible to increase the yield of 2i synthesis from 29 to 43%.

Suzuki Reaction

To estimate the effect of the elongation of the conjugated system of phenylene rings on the spectral properties of star-shaped BDF, the 2i, an analogue of 2b, was prepared using the Suzuki reaction (Scheme ).
Scheme 3

Suzuki Synthesis of 2j

Commercially available 4-(diphenylamino)phenylboronic acid pinacol ester was reacted with TBBDF using [Pd(dppf)Cl]2, 3 M aqueous K3PO4, and 1,4-dioxane to obtain the target compound in a high 90% yield.

Photophysical Properties

The star-shaped BDF derivatives were analyzed using ultraviolet–visible (UV–vis) (Supporting Information) and photoluminescence spectroscopies. Most of the obtained compounds revealed strong fluorescence both in solution and in solid states. Compounds 2b and 2f–2h revealed the highest, ∼100% quantum yield (QY) in toluene and chloroform. In addition, all these compounds have almost identical emission spectra profiles and maxima in a very narrow 418.4–419.8 nm range. In toluene, 2a, 2d, 2e, and 2i (Figure ) had broad emission with one maximum, while 2b, 2c, 2f–2h, and 2j had two or three maxima. The latter compounds show structured emission spectra and exhibit no or marginal solvatochromic effect (chloroform vs toluene). Moreover, Stoke’s shift values for these emitters are rather small, 36–43 nm. These observations are typical of molecules with no or very little change in geometry after excitation. On the other hand, compounds 2a, 2d–e, and 2i show structureless emission spectra and exhibit substantial solvatochromism; the bathochromic effect was observed by changing the solvent from toluene to chloroform (Table ). Stoke’s shifts are much larger (80, 118, 61, and 76 nm for 2a, 2d, 2e, and 2i, respectively), which are typical for molecules whose excited-state geometry differ substantially from the geometry of the ground state. The elongation of the conjugated phenylene ring system (2j vs 2b) slightly shifted the emission maximum toward longer wavelengths and decreased QY by 15% but did not affect the emission spectrum profile. On analyzing the UV–vis spectra of 2a–2j in toluene and chloroform, it can be seen that they are rather insensitive to solvent change (Figure ). We found it interesting, bearing in mind some bathochromic shifts in emission spectra, so we decided to support these observations with computational chemistry methods.
Figure 1

Normalized emission spectra of (a) 2a–2e and (b) 2f–2j in toluene. Excitation wavelength λex = 366 nm. The concentration is set to an absorbance value between 0.06 and 0.11 to avoid the inner filter effect. The spectra are normalized to the maximal intensity.

Table 5

Physical Properties of BDFs 2a–2j in Toluene and Chloroform Solutions

 toluene solution
chloroform solution
comp.λabs (nm)λem (nm)Stoke’s shift (nm)QYFaτF (ns)HOMOb (eV)LUMOb (eV)Egb (eV)Egc (eV)λabs (nm)toluene to chloroform difference in λem (nm)QYFaτF (ns)HOMOb (eV)LUMOb (eV)
2a334414800.364.32–5.37–1.673.103.0133616 nm bat.d0.250.09–5.38–1.68
 367        368     
2b379418391.010.87–4.88–1.392.902.86377no1.040.84–4.93–1.44
 397              
2c399437380.830.91–5.04–1.682.793.01360marginal0.750.82–5.07–1.67
 419        373     
2d3704881180.061.93–5.22–1.533.122.9737026 nm bat.0.040.24–5.24–1.55
2e369430610.773.11–5.23–1.603.113.0436929 nm bat.0.655.11–5.27–1.61
2f383420370.920.82–5.27–1.613.072.97382marginal1.090.86–5.29–1.63
2g384420360.990.82–5.24–1.603.052.98382marginal1.070.82–5.27–1.62
2h342419770.951.24–5.40–1.893.032.99343none1.072.29–5.41–1.83
 380        378     
2i393470770.722.58–4.86–1.592.832.8839326 nm bat.0.464.76–4.90–1.59
2j398441430.850.72–5.03–1.572.902.85398marginal0.940.73–5.08–1.64

Values above 1 can occur due to the statistical error of ±0.1 for the QY.

Calculated at the PBE0/6-31G* level of theory with GD3 empirical dispersion.

Estimated from the UV–vis spectrum onset.

bat. = bathochromic.

Figure 2

Normalized absorption spectra of (a) 2a–2e in toluene, (b) 2a–2e in chloroform, (c) 2f–2j in toluene, and (d) 2f–2j in chloroform.

Normalized emission spectra of (a) 2a–2e and (b) 2f–2j in toluene. Excitation wavelength λex = 366 nm. The concentration is set to an absorbance value between 0.06 and 0.11 to avoid the inner filter effect. The spectra are normalized to the maximal intensity. Normalized absorption spectra of (a) 2a–2e in toluene, (b) 2a–2e in chloroform, (c) 2f–2j in toluene, and (d) 2f–2j in chloroform. Values above 1 can occur due to the statistical error of ±0.1 for the QY. Calculated at the PBE0/6-31G* level of theory with GD3 empirical dispersion. Estimated from the UV–vis spectrum onset. bat. = bathochromic.

Computational Results

Due to the structural flexibility of investigated systems, the first step was identifying the most representative rotamers for which absorption spectra should be calculated. This task was performed with the help of the CREST software,[58,59] which provides an automated scheme for finding rotamers based on the semiempirical tight-binding GFN2-xTB method[60] coupled to meta-dynamics simulations.[59] At first, in the case of every investigated system, hydrocarbon chains were replaced with methyl groups. Then, CREST calculations were performed, and as a result, the sets of rotamers were obtained. The rotamers with the lowest energy were taken to further calculations: they were enlarged by missing hydrocarbon groups and optimized within the PBE0/6-31G(*) approach with and without Grimme’s GD3 empirical dispersion correction[60] provided by the Gaussian 19 package. Then, for every investigated system, the UV absorption spectra were recorded using several solvents: chloroform, dichloromethane (DCM), dimethyl sulfoxide (DMSO), tetrahydrofuran (THF), and toluene. Solvents were mimicked by the polarizable continuum model, and the gas-phase geometry of the system was used. All bands for all investigated systems were found to be the π–π*-type transitions. For all systems, the lowest unoccupied molecular orbital (LUMO) orbitals lie on the BDF chain (Figures and S23–S32). However, the position of the highest occupied molecular orbital (HOMO) orbitals let us divide investigated molecules into two groups. The first one consists of 2a–b, 2d, 2f–g, and 2j, where the HOMO orbitals lie on the BDF core, and the second is 2c, 2e, and 2h–i, where the HOMO orbitals occupy the outer part of the molecule. One could expect that manifested charge transfer in the second group will exhibit a more significant impact of the solvent on absorption or emission spectra. In Table , we compare S0 → S1 excitation wavelengths for different solvents (with toluene as a reference). Indeed, for the second group of molecules, the changes are much more significant. Additionally, the Δδ index,[62] which is the overall difference of root-mean-square deviation of electron and hole distributions, was calculated in MultiWFn,[63] for S0 → S1 excitation of the given system in toluene. The Δδ parameter allowed us to quantify the CT for the analyzed star systems. For 2c, 2e, and 2h–i, the absolute value of Δδ (4.46, 4.75, and 6.00, respectively) is much larger than for other systems. It indicates that for the star-shaped benzodifurans and similar systems, Δδ can be a good index for the charge transfer estimation. To provide a simple interpretation of excitation, the natural transition orbitals[61] have been obtained for the S0 → S1 excitation (the corresponding data are presented in the Supporting Information).
Figure 3

HOMO and LUMO orbitals of 2a and 2c calculated within the PBE0/6-31G* level of theory with GD3 empirical dispersion.

Table 6

Increase of the Wavelength [nm] for the First Absorption Line Regarding Toluene

 Δλa
comp.THFchloroformDCMDMSOΔδ
2a2.271.432.202.860.95
2b–0.35–0.37–0.73–1.391.20
2c9.056.239.8513.644.46
2d1.821.071.732.370.62
2e5.003.435.497.714.75
2f2.371.522.373.151.63
2g2.291.442.253.011.68
2h6.114.316.428.353.65
2i8.215.539.0013.096.00
2j–0.14–0.23–0.45–0.861.89

Δλ = λabs,toluene – λabs,solvent; calculated at the PBE0/6-31G* level of theory with GD3 empirical dispersion at the geometry for the gas phase. Δδ index calculated for toluene.

HOMO and LUMO orbitals of 2a and 2c calculated within the PBE0/6-31G* level of theory with GD3 empirical dispersion. Δλ = λabs,toluene – λabs,solvent; calculated at the PBE0/6-31G* level of theory with GD3 empirical dispersion at the geometry for the gas phase. Δδ index calculated for toluene.

Conclusions

In conclusion, the condition development for palladium-catalyzed amination of bromobenzene with Cz, DPA, PXZ, PTX, and DMAC was performed. The best catalytic system for palladium-catalyzed coupling with Cz proved to be TrixiePhos/t-BuOLi/toluene, with DPA, PXZ, and PTX—XPhos/t-BuONa/toluene, and with DMAC—t-BuXPhos/t-BuONa/toluene. Based on these results, the Buchwald–Hartwig reaction between the benzodifuran core (TBBDF) and the amines mentioned above, and their more extended derivatives, led to desired star-shaped benzodifurans in good to excellent yields. Most of the synthesized compounds revealed an exceptionally good fluorescence in the 400–550 nm range with a QY of up to 100%. TDDFT calculations of absorption spectra showed a small solvatochromic effect with a change in the polarity of the solvent.

Experimental Section

General Experimental Methods

Experiments with air- and moisture-sensitive materials were carried under an argon atmosphere. Glassware was oven-dried for several hours, assembled hot, and cooled in a stream of argon. Silica gel 60, Merck 230–400 mesh, was used for preparative column flash chromatography. Analytical thin-layer chromatography (TLC) was performed using Merck TLC silica gel 60 F254 0.2 mm plates. Allylpalladium(II) chloride dimer, other palladium catalysts, phosphines, 4-(diphenylamino)phenylboronic acid pinacol ester, and other commercially available reagents were from Sigma-Aldrich, Merck, or Fluorochem and were used without further purification. 2,3,6,7-Tetrakis(4-bromophenyl)-4,8-didecylbenzo[1,2-b:4,5-b′]difuran (TBBDF),[55]tert-butyl-3,6-dibromo-9H-carbazole-9-carboxylate (DBBocCz),[57] 3,6-di-tert-butyl-9H-carbazole,[64] 3,6-diiodo-9-tosyl-9H-carbazole (DITosCz),[65] and 3,6-diiodo-9H-carbazole (DICz)[65] were synthesized according to a literature procedure. Solvents were purchased from Avantor, VWR, and Sigma-Aldrich. 1,4-Dioxane, toluene, and THF were distilled from sodium benzophenone ketyl before use. DCM, chloroform, DMSO, acetone, methanol, diethyl ether, and ethyl acetate were dried with molecular sieves and used without further purification. 1H and 13C NMR spectra were recorded on a Bruker Avance III 400 MHz or Bruker Avance III 700 MHz instrument at ambient temperature. Chemical shifts are reported in parts per million (δ scale), and coupling constants (J values) are listed in hertz. Structural assignments were made with additional information from gCOSY, gHSQC, and gHMBC experiments. GC–MS analyses were performed on a Shimadzu GCMS-TQ8040 system, and detector response was calibrated on substrate and product standards. IR spectra were recorded on a PerkinElmer Spectrum Two FT-IR Spectrometer. The melting points were determined with a Büchi SMP 32 and Barnstead Thermolyne Mel-Temp II apparatus in open capillaries and are uncorrected. Elemental analyses were performed using an Elementar Analysensysteme GmbH Vario MACRO CHNanalyzer.

Spectroscopic Measurements

Toluene and chloroform (spectrometric grade from Merck) were employed as solvents for absorption and fluorescence measurements. UV–vis absorption spectra were recorded on a PerkinElmer UV–vis Lambda 25 spectrometer in a 1 cm quartz cell compared to solvent blank. Emission spectra were obtained on a JASCO FP-8500 spectrometer. The QY was determined using 9,10-diphenylanthracene in toluene (θref = 0.95) at λex = 366 nm. The concentration of 9,10-diphenylanthracene and the analyzed substances were set so that the absorbance at 366 nm was low enough to avoid the inner filter effect. The fluorescence lifetime was determined using a time-correlated single-photon counting setup with a Maestro spectrum analyzer (EG&G Ortec, Oak Ridge, USA) and a pulsed LED (376 nm, PicoQuant GmbH, Berlin, Germany) with a pulse width of fewer than 1.5 ns (full width at half-maximum). All fluorescence light above 406 nm was detected using a low-pass filter. The decay traces were analyzed assuming a single exponential decay function.

Amination Screening

In a pressure vial closed with a septum, an amine (1.62 mmol) and a base (1.62 mmol) were mixed in a dry solvent (4 mL) and stirred for 5 min under argon. In a separate vial, [Pd(allyl)Cl]2 (0.016 mmol; 5.9 mg; 1 mol %) and phosphine ligand (0.065 mmol; 4 mol %) in a dry solvent (1.5 mL) were stirred under argon for 5 min. Bromobenzene (1.62 mmol) and the catalyst mixture were added to the pressure vial, the septum was replaced by a screw cap, the vial was immersed in an oil bath, and the mixture was stirred at 100 °C for 24 h. After this time, the reaction mixture was cooled to room temperature and analyzed by GC–MS.

Synthesis of BDF Derivatives

9,9′,9″,9‴-((4,8-Didecylbenzo[1,2-b:4,5-b′]difuran-2,3,6,7-tetrayl)tetrakis(benzene-4,1-diyl))tetrakis(9H-carbazole) (2a)

In a 10 mL vial, [Pd(allyl)Cl]2 (0.006 mmol; 2.2 mg; 4 mol %) and TrixiePhos (0.024 mmol; 9.6 mg; 16 mol %) were mixed in dry, degassed toluene (3 mL) and stirred for 10 min in an inert gas atmosphere. In a Schlenk flask, 9H-carbazole (0.9 mmol; 150 mg) was dissolved in dry, degassed toluene (10 mL), t-BuONa (0.9 mmol; 86 mg) was added, and the mixture was stirred for 5 min under argon. 2,3,6,7-Tetrakis(4-bromophenyl)-4,8-didecylbenzo[1,2-b:4,5-b′]difuran (TBBDF) (0.15 mmol; 158 mg) was added, followed by the catalyst mixture, and the flask was immersed in an oil bath preheated to 100 °C and stirred at this temperature for 24 h. It was cooled to room temperature and poured into MeOH (40 mL). The precipitate was filtered off; washed with H2O (5 mL), MeOH (2 × 5 mL), and Et2O (2 mL); and dried to afford 191 mg of light beige solid (90%). Although, NMR analysis revealed high purity of the desired product, flash chromatography, AcOEt/PE 2:8, was performed, but no changes in purity and product mass were observed. 1H NMR (CDCl3, 700 MHz): δ [ppm] 8.20 (d, J = 7.7 Hz, 4H, 4CHAr), 8.15 (d, J = 7.8 Hz, 4H, 4CHAr), 7.91–7.85 (m, 8H, 8CHAr), 7.84–7.80 (m, 4H, 4CHAr), 7.61–7.55 (m, 8H, 8CHAr), 7.51–7.46 (m, 8H, 8CHAr), 7.42 (t, J = 7.5 Hz, 4H, 4CHAr), 7.34 (t, J = 7.4 Hz, 4H, 4CHAr), 7.31–7.29 (t, J = 7.5 Hz, 4H, 4CHAr), 3.00–2.94 (m, 4H, 2CH2), 1.73–1.69 (m, 4H, 2CH2), 1.34–1.10 (m, 28H, 14CH2), 0.79 (t, J = 7.2 Hz, 6H, 2CH3). 13C{1H} NMR (100 MHz, CDCl3): δ [ppm] 150.0 (2CAr), 140.8 (4CAr), 140.6 (4CAr), 137.8 (2CAr), 137.4 (4CAr), 133.8 (2CAr), 132.4 (4CHAr), 129.9 (2CAr), 127.7 (4CHAr), 127.6 (4CHAr), 126.9 (4CHAr), 126.1 (4CHAr), 126.0 (4CHAr), 123.6 (2CAr), 123.6 (2CAr), 120.5 (4CHAr), 120.4 (4CHAr), 120.2 (4CHAr), 120.2 (4CHAr), 118.4 (2CAr), 116.4 (8CAr), 109.8 (4CHAr), 109.7 (4CHAr), 31.8 (2CH2), 31.2 (2CH2), 30.3 (2CH2), 29.7 (2CH2), 29.7 (2CH2), 29.6 (2CH2), 29.4 (2CH2), 25.9 (2CH2), 22.6 (2CH2), 14.0 (2CH3). IR νmax cm–1: 1451 (s), 1228 (s), 747 (s). mp: 309–310 °C. Anal. Calcd for C102H90N4O2: C, 87.27; H, 6.46; N, 3.99; O, 2.28. Found: C, 87.60; H, 6.42; N, 4.01; O, 2.32.

4,4′,4″,4‴-(4,8-Didecylbenzo[1,2-b:4,5-b′]difuran-2,3,6,7-tetrayl)tetrakis(N,N-diphenylaniline) (2b)

This compound was prepared according to the procedure for 2a using XPhos (0.024 mmol; 11.5 mg; 16 mol %) and diphenylamine (0.9 mmol; 152 mg) to obtain 196 mg of light green solid (92%). 1H NMR (CDCl3, 700 MHz): δ [ppm] 7.49 (d, J = 8.8 Hz, 4H, 4CHAr), 7.38 (d, J = 8.5 Hz, 4H, 4CHAr), 7.32–7.27 (m, 16H, 16CHAr), 7.22–7.18 (m, 12H, 12CHAr), 7.15 (d, J = 8.4 Hz, 8H, 8CHAr), 7.10–7.05 (m, 8H, 8CHAr), 7.00 (d, J = 8.9 Hz, 4H, 4CHAr), 2.82–2.75 (m, 4H, 2CH2), 1.56–1.52 (m, 4H, 2CH2), 1.29–1.19 (m, 28H, 14CH2), 0.86 (t, J = 7.2 Hz, 6H, 2CH3). 13C{1H} NMR (175 MHz, CDCl3): δ [ppm] 149.6 (2CAr), 147.8 (6CAr), 147.5 (6CAr), 147.3 (4CAr), 131.7 (4CHAr), 129.3 (16CAr), 127.0 (4CHAr), 125.9 (2CAr), 125.2 (2CAr), 124.8 (8CAr), 124.6 (8CHAr), 123.6 (4CHAr), 123.3 (4CHAr), 123.0 (4CHAr), 122.6 (4CHAr), 115.6 (4CAr), 31.9 (2CH2), 30.9 (2CH2), 30.1 (2CH2), 29.7 (2CH2), 29.6 (2CH2), 29.5 (2CH2), 29.4 (2CH2), 25.6 (2CH2), 22.6 (2CH2), 14.0 (2CH3). IR νmax cm–1: 1460 (s), 740 (s). mp: 211–212 °C. Anal. Calcd for C102H98N4O2: C, 86.77; H, 7.00; N, 3.97; O, 2.27. Found: C, 86.34; H, 7.04; N, 3.99; O, 2.17.

10,10′,10″,10‴-((4,8-Didecylbenzo[1,2-b:4,5-b′]difuran-2,3,6,7-tetrayl)tetrakis(benzene-4,1-diyl))tetrakis(10H-phenoxazine) (2c)

This compound was prepared according to the procedure for 2a using XPhos (0.024 mmol; 11.5 mg; 16 mol %) and 10H-phenoxazine (0.9 mmol; 165 mg) to obtain 196 mg of light green solid (92%). 1H NMR (CDCl3, 700 MHz): δ [ppm] 7.86–7.82 (m, 4H, 4CHAr), 7.80–7.75 (m, 4H, 4CHAr), 7.60–7.55 (m, 4H, 4CHAr), 7.31–7.27 (m, 4H, 4CHAr), 6.76–6.57 (m, 24H, 24CHAr), 6.11–6.06 (m, 4H, 4CHAr), 6.01–5.95 (m, 4H, 4CHAr), 2.88–2.83 (m, 4H, 2CH2), 1.66–1.59 (m, 4H, 2CH2), 1.33–1.16 (m, 28H, 14CH2), 0.82 (t, J = 7.2 Hz, 6H, 2CH3). 13C{1H} NMR (100 MHz, CDCl3): δ [ppm] 150.0 (2CAr), 144.1 (2CAr), 144.0 (2CAr), 139.1 (2CAr), 138.7 (2CAr), 135.2 (2CAr), 134.2 (2CAr), 134.1 (4CAr), 133.5 (4CHAr), 131.8 (4CHAr), 131.0 (2CAr), 130.9 (4CHAr), 128.6 (4CHAr), 126.1 (4CAr), 123.3 (4CHAr), 123.3 (4CHAr), 121.7 (4CHAr), 121.5(4CHAr), 118.6 (2CAr), 116.4 (8CAr), 115.7 (4CHAr), 115.6 (4CHAr), 113.2 (4CHAr), 113.1 (4CHAr), 32.0 (2CH2), 31.0 (2CH2), 30.0 (2CH2), 29.7 (2CH2), 29.6 (2CH2), 29.5 (2CH2), 29.4 (2CH2), 25.8 (2CH2), 22.7 (2CH2), 14.1 (2CH3). IR νmax cm–1: 1485 (s), 1269 (s), 739 (s). mp: 307–308 °C. Anal. Calcd for C102H90N4O6: C, 83.46; H, 6.18; N, 3.82; O, 6.54. Found: C, 83.34; H, 6.13; N, 3.79; O, 6.58.

10,10′,10″,10‴-((4,8-Didecylbenzo[1,2-b:4,5-b′]difuran-2,3,6,7-tetrayl)tetrakis(benzene-4,1-diyl))tetrakis(10H-phenothiazine) (2d)

This compound was prepared according to the procedure for 2a using XPhos (0.024 mmol; 11.5 mg; 16 mol %) and 10H-phenothiazine (0.9 mmol; 179 mg) to obtain 166 mg of light green solid (75%). 1H NMR (CDCl3, 700 MHz): δ [ppm] 7.83 (d, J = 8.3 Hz, 4H, 4CHAr), 7.74 (d, J = 8.6 Hz, 4H, 4CHAr), 7.60 (d, J = 8.3 Hz, 4H, 4CHAr), 7.30–7.27 (m, 4H, 4CHAr), 7.13 (dd, J = 7.5, 1.6 Hz, 8H, 8CHAr), 6.98–6.94 (m, 8H, 8CHAr), 6.92–6.89 (m, 8H, 8CHAr), 6.52–6.48 (m, 8H, 8CHAr), 2.92–2.88 (m, 4H, 2CH2), 1.67–1.62 (m, 4H, 2CH2), 1.32–1.20 (m, 28H, 14CH2), 0.86 (t, J = 7.2 Hz, 6H, 2CH3). 13C{1H} NMR (175 MHz, CDCl3): δ [ppm] 150.2 (2CAr), 149.9 (2CAr), 143.9 (4CAr), 143.6 (4CAr), 141.7 (2CAr), 141.5 (2CAr), 134.4 (2CAr), 133.1 (4CHAr), 130.5 (4CHAr), 129.5 (2CAr), 128.2 (4CHAr), 127.9 (4CHAr), 127.2 (4CHAr), 127.1 (4CHAr), 126.9 (8CHAr), 126.0 (2CAr), 123.2 (4CHAr), 123.1 (4CAr), 122.9 (4CHAr), 121.8 (4CAr), 118.2 (2CAr), 118.1 (4CHAr), 116.9 (4CHAr), 116.2 (2CAr), 31.8 (2CH2), 31.0 (2CH2), 29.9 (2CH2), 29.6 (2CH2), 29.5 (4CH2), 29.3 (2CH2), 25.8 (2CH2), 22.6 (2CH2), 14.0 (2CH3). IR νmax cm–1: 1466 (s), 1229 (s), 723 (s). mp: 307–308 °C. Anal. Calcd for C102H90N4O2S4: C, 79.96; H, 5.92; N, 3.66; O, 2.09; S, 8.37. Found: C, 80.39; H, 5.97; N, 3.53; O, 2.12; S, 8.35.

10,10′,10″,10‴-((4,8-Didecylbenzo[1,2-b:4,5-b′]difuran-2,3,6,7-tetrayl)tetrakis(benzene-4,1-diyl))tetrakis(9,9-dimethyl-9,10-dihydroacridine) (2e)

This compound was prepared according to the procedure for 2a using t-BuXPhos (0.024 mmol; 10.2 mg; 16 mol %) and DMAC (0.9 mmol; 188 mg). After 24 h, the reaction mixture was cooled to RT and transferred into a separatory funnel. DCM (20 mL) and water (50 mL) were added, and the layers were separated. The aqueous layer was extracted with DCM (3 × 20 mL). Combined organic layers were dried over anhydrous magnesium sulfate and concentrated. Purification was done by flash chromatography using DCM/PE (1:1) as an eluent to obtain 61 mg of light green solid (19%). 1H NMR (CDCl3, 700 MHz): δ [ppm] 7.95–7.90 (m, 8H, 8CHAr), 7.61 (d, J = 8.3 Hz, 4H, 4CHAr), 7.53–7.49 (m, 8H, 8CHAr), 7.34 (d, J = 8.6 Hz, 4H, 4CHAr), 7.05–6.95 (m, 16H, 16CHAr), 6.51 (dd, J = 8.1, 1.1 Hz, 4H, 4CHAr), 6.38 (dd, J = 8.2, 1.12 Hz, 4CHAr), 3.00–2.98 (m, 4H, 2CH2), 1.75 (s, 12H, 4CH3), 1.73 (s, 12H, 4CH3), 1.37–1.16 (m, 32H, 16CH2), 0.82 (t, J = 7.2 Hz, 6H, 2CH3). 13C{1H} NMR (175 MHz, CDCl3): δ [ppm] 150.2 (2CAr), 150.1 (2CAr), 144.4 (2CAr), 141.1 (2CAr), 140.8 (8CAr), 135.0 (2CAr), 133.4 (4CHAr), 132.3 (4CHAr), 131.3 (4CHAr), 130.8 (2CAr), 130.4 (4CAr), 130.3 (4CAr), 128.5 (4CHAr), 126.4 (4CHAr), 126.4 (4CHAr), 126.2 (2CAr), 125.3 (4CHAr), 125.2 (4CHAr), 120.8 (4CHAr), 120.8 (4CHAr), 118.8 (2CAr), 116.4 (2CAr), 114.1 (4CHAr), 114.0 (4CHAr), 36.1 (2C), 36.0 (2C), 31.8 (2CH2), 31.1 (8CH3), 31.0 (2CH2), 29.9 (2CH2), 29.6 (2CH2), 29.6 (2CH2), 29.5 (2CH2), 29.3 (2CH2), 25.8 (2CH2), 22.6 (2CH2), 14.0 (2CH3). IR νmax cm–1: 1466 (s), 1268 (s), 742 (s). mp: 285–288 °C. Anal. Calcd for C114H114N4O2: C, 87.09; H, 7.31; N, 3.56; O, 2.04. Found: C, 87.00; H, 7.27; N, 3.58; O, 2.09.

3,6-Di(dec-1-yn-1-yl)-9H-carbazole

In a round-bottom flask, 3,6-diiodocarbazole (DICz) (20 mmol; 8.38 g), Pd(dppf)Cl2 (0.27 mmol; 0.198 g), and CuI (0.54 mmol; 0.103 g) were dissolved in dry, degassed toluene (50 mL). Then, i-Pr2NH (80 mmol; 11.2 mL) was added, and after 5 min, 1-decyne (50 mmol; 6.91 g; 9 mL) was added dropwise. The flask was immersed in an oil bath at 70 °C for 3 h. The reaction mixture was then cooled to RT, and water (200 mL) was added. The solution was extracted with ethyl acetate (3 × 60 mL) and then washed with citric acid, NaHCO3, water, and brine. The extract was dried over anhydrous MgSO4 and concentrated to afford 9.77 g of the product that was taken into the next step without purification. 1H NMR (CDCl3, 700 MHz): δ [ppm] 8.11 (s, 2H, 2CHAr), 8.08 (s, 1H, NH), 7.48 (dd, J = 8.3, 1.6 Hz, 2H, 2CHAr), 7.32 (d, J = 8.3 Hz, 2H, 2CHAr), 2.48 (t, J = 7.2 Hz, 4H, 2CH2), 1.70–1.64 (m, 4H, 2CH2), 1.54–1.49 (m, 4H, 2CH2), 1.41–1.29 (m, 16H, 8CH2), 0.93 (t, J = 7.0 Hz, 6H, 2CH3). 13C{1H} NMR (175 MHz, CDCl3): δ [ppm] 139.0 (2CAr), 129.8 (2CHAr), 123.8 (2CHAr), 123.0 (2CAr), 115.5 (2CAr), 110.5 (2CHAr), 88.4 (2Calk), 81.3 (2Calk), 31.9 (2CH2), 29.2 (2CH2), 29.2 (2CH2), 29.0 (4CH2), 22.6 (2CH2), 19.5 (2CH2), 14.0 (2CH3). IR νmax cm–1: 1469 (s), 1254 (s), 714 (m). mp: 75–76 °C. Anal. Calcd for C32H41N: C, 87.41; H, 9.40; N, 3.19. Found: C, 87.87; H, 9.41; N, 3.14.

3,6-Didecyl-9H-carbazole (1a)

In a round-bottom flask, 3,6-di(dec-1-yn-1-yl)-9H-carbazole (20.0 mmol; 8.80 g) was dissolved in degassed ethyl acetate (100 mL) under nitrogen at RT. Then, Pd/C (10% w/w; 1.20 g) was added and stirred at 50 °C under an atmosphere of hydrogen. After 12 h, the mixture was cooled to RT and filtered over Celite, washed with ethyl acetate, and evaporated to dryness on a rotary evaporator. The crude product was purified by flash chromatography using EA/PE (1:9) as an eluent. The product was obtained as a light beige solid, 5.60 g (64%). 1H NMR (CDCl3, 700 MHz): δ [ppm] 7.88 (s, 2H, 2CHAr), 7.86 (s, 1H, NH), 7.33 (d, J = 8.2 Hz, 2H, 2CHAr), 7.24 (dd, J = 8.2, 1.6 Hz, 2H, 2CHAr), 2.80 (t, J = 7.8 Hz, 4H, 2CH2), 1.77–1.69 (m, 4H, 2CH2), 1.43–1.25 (m, 28H, 9CH2), 0.91 (t, J = 7.1 Hz, 6H, 2CH3). 13C{1H} NMR (175 MHz, CDCl3): δ [ppm] 138.3 (2CAr), 133.9 (2CAr), 126.4 (2CHAr), 123.5 (2CAr), 119.5 (2CHAr), 110.2 (2CHAr), 36.1(2CH2), 32.2 (2CH2), 31.9 (2CH2), 29.6 (4CH2), 29.4 (2CH2), 29.3 (2CH2), 22.7 (2CH2), 14.1 (2CH3). IR νmax cm–1: 1248 (m), 723 (m). mp: 62–63 °C. Anal. Calcd for C32H49N: C, 85.84; H, 11.03; N, 3.13. Found: C, 85.43; H, 11.12; N, 3.01.

9,9′,9″,9‴-((4,8-Didecylbenzo[1,2-b:4,5-b′]difuran-2,3,6,7-tetrayl)tetrakis(benzene-4,1-diyl))tetrakis(3,6-didecyl-9H-carbazole) (2f)

This compound was prepared according to the procedure for 2a except TBBDF (0.25 mmol; 264 mg), 3,6-didecylcarbazole (1.5 mmol; 672 mg), [Pd(allyl)Cl]2 (0.02 mmol; 7.3 mg; 8 mol %), t-BuXPhos (0.08 mmol; 29.3 mg; 32 mol %), and t-BuONa (1.5 mmol; 144 mg). Product as a light green solid, 386 mg (61%). 1H NMR (CDCl3, 700 MHz): δ [ppm] 7.98 (d, J = 1.1 Hz, 4H, 4CHAr), 7.93 (d, J = 1.2 Hz, 4H, 4CHAr), 7.88–7.81 (m, 12H, 12CHAr), 7.59 (d, J = 8.6 Hz, 4H, 4CHAr), 7.49 (d, J = 8.3 Hz, 4H, 4CHAr), 7.42 (d, J = 8.3 Hz, 4H, 4CHAr), 7.30 (dd, J = 8.4, 1.5 Hz, 4H, 4CHAr), 7.24 (dd, J = 8.4, 1.6 Hz, 4H, 4CHAr), 3.01–2.94 (m, 4H, 2CH2), 2.86–2.79 (m, 16H, 8CH2), 1.79–1.70 (m, 20H, 10CH2), 1.46–1.14 (s, 140H, 70CH2), 0.92–0.89 (td, J = 7.1, 1.8 Hz, 24H, 8CH3), 0.82 (t, J = 7.2 Hz, 6H, 2CH3). 13C{1H} NMR (175 MHz, CDCl3): δ [ppm] 150.4 (2CAr), 150.1 (2CAr), 139.5 (4CAr), 139.3 (4CAr), 138.3 (2CAr), 138.0 (2CAr), 134.8 (4CAr), 134.7 (4CAr), 133.4 (2CAr), 132.3 (4CHAr), 129.5 (2CAr), 127.7 (4CHAr), 127.3 (4CHAr), 126.6 (4CHAr), 126.6 (4CHAr), 126.5 (4CHAr), 126.1 (2CAr), 123.8 (4CHAr), 123.7 (4CAr), 119.7 (4CHAr), 119.6 (4CHAr), 118.3 (2CHAr), 116.2 (2CHAr), 109.5 (4CHAr), 109.3 (4CHAr), 34.8 (4CH2), 36.0 (4CH2), 32.3 (4CH2), 32.2 (4CH2), 31.9 (8CH2), 31.8 (2CH2), 31.2 (2CH2), 30.3 (2CH2), 29.7 (2CH2), 29.7 (2CH2), 29.6 (8CH2), 29.6 (10CH2), 29.6 (4CH2), 29.6 (4CH2), 29.4 (6CH2), 29.4 (4CH2), 29.3 (10CH2), 22.6 (8CH2), 22.6 (2CH2), 14.0 (8CH3), 14.0 (2CH3). IR νmax cm–1: 1462 (s), 1232.10 (m). mp: 216–217 °C. Anal. Calcd for C182H250N4O2: C, 86.54; H, 9.98; N, 2.22; O, 1.27. Found: C, 86.21; H, 9.86; N, 2.27; O, 1.34.

9,9′,9″,9‴-((4,8-Didecylbenzo[1,2-b:4,5-b′]difuran-2,3,6,7-tetrayl)tetrakis([1,1′-biphenyl]-4′,4-diyl))tetrakis(3,6-di-tert-butyl-9H-carbazole) (2g)

This compound was prepared according to the procedure for 2a except TBBDF (0.25 mmol; 264 mg), 3,6-di-tert-butyl-9H-carbazole (1.5 mmol; 418 mg), [Pd(allyl)Cl]2 (0.02 mmol; 7.3 mg; 8 mol %), t-BuXPhos (0.08 mmol; 29.3 mg; 32 mol %), and t-BuONa (1.5 mmol; 144 mg). After 24 h, the reaction mixture was cooled to RT and transferred into a separatory funnel. DCM (20 mL) and water (50 mL) were added, and the layers were separated. An aqueous layer was extracted with DCM (3 × 20 mL). The combined organic layers were dried over anhydrous magnesium sulfate and concentrated. The crude product was stirred in MeOH (50 mL) at 65 °C for 0.5 h, and the solid phase was filtered off. Then, the brown solid was stirred in ethyl acetate (50 mL) at 60 °C for 1 h, and the solid phase was filtered off and dried to obtain the product as a beige light solid, 288 mg (62%). 1H NMR (CDCl3, 700 MHz): δ [ppm] 8.21 (d, J = 1.8 Hz, 4H, 4CHAr), 8.17 (d, J = 1.9 Hz, 4H, 4CHAr), 7.89–7.87 (m, 4H, 4CHAr), 7.85–7.81 (m, 8H, 8CHAr), 7.60 (d, J = 8.6 Hz, 4H, 4CHAr), 7.57–7.55 (m, 4H, 4CHAr), 7.53–7.49 (m, 8H, 8CHAr), 7.47–7.45 (m, 4H, 4CHAr), 3.02–2.97 (m, 4H, 2CH2), 1.74–1.68 (m, 4H, 2CH2), 1.52 (s, 36H, 12CH3), 1.50 (s, 36H, 12CH3), 1.27–1.16 (m, 28H, 14CH2), 0.82 (t, J = 7.2 Hz, 6H, 2CH3). 13C{1H} NMR (175 MHz, CDCl3): δ [ppm] 150.5 (2CAr), 150.1 (2CAr), 143.2 (8CAr), 139.2 (8CAr), 139.0 (8CAr), 138.3 (2CAr), 138.0 (2CAr), 133.5 (2CAr), 132.3 (4CHAr), 129.5 (2CAr), 127.7 (4CHAr), 127.2 (4CHAr), 126.4 (4CHAr), 126.1 (2CAr), 123.8 (4CHAr), 123.7 (4CHAr), 123.6 (2CAr), 118.4 (2CAr), 116.3 (4CHAr), 116.2 (4CHAr), 109.4 (4CHAr), 109.2 (4CHAr), 34.8 (4C), 34.7 (4C), 32.0 (12CH3), 32.0 (12CH3), 31.9 (2CH2), 31.2 (2CH2), 30.3(2CH2), 29.8 (2CH2), 29.7 (2CH2), 29.6 (2CH2), 29.4 (2CH2), 25.9 (2CH2), 22.6 (2CH2), 14.0 (2CH3). IR νmax cm–1: 1473 (s). mp: >400 °C. Anal. Calcd for C134H154N4O2: C, 86.87; H, 8.38; N, 3.02; O, 1.73. Found: C, 86.68; H, 8.45; N, 2.99; O, 1.76.

9′-Tosyl-9′H-9,3’:6′,9″-tercarbazole[56]

In a 10 mL vial, [Pd(allyl)Cl]2 (0.2 mmol; 73.2 mg; 1 mol %) and t-BuXPhos (0.8 mmol; 340 mg; 4 mol %) were mixed in dry, degassed 1,4-dioxane (5 mL) and stirred for 5 min in an inert gas atmosphere. In a round-bottom flask, 9H-carbazole (42 mmol; 7.014 g) was dissolved in dry, degassed 1,4-dioxane (130 mL), t-BuOLi (1 M in THF, 42 mmol; 42 mL) was added, and the mixture was stirred for 5 min under argon. 3,6-Diiodo-9-tosyl-9H-carbazole (DITosCz) (20 mmol; 11.460 g) was added, followed by the catalyst mixture, and the flask was immersed in an oil bath preheated to 100 °C and stirred at this temperature for 24 h. It was cooled to room temperature and poured into MeOH (250 mL). The precipitate was filtered off; washed with H2O (25 mL), MeOH (2 × 50 mL), and Et2O (20 mL); and dried to afford 8.925 g of light beige solid (68%). However, NMR analysis revealed high purity of the desired product; flash chromatography, DCM/PE 1:1, was performed, but no changes in purity and product mass were observed. 1H NMR (CDCl3, 700 MHz): δ [ppm] 8.64 (d, J = 8.9 Hz, 2H, 2CHAr), 8.17 (d, J = 7.6 Hz, 4H, 4CHAr), 8.12 (d, J = 2.1 Hz, 2H, 2CHAr), 7.97 (d, J = 8.4 Hz, 2H, 2CHAr), 7.76 (dd, J = 8.9, 2.1 Hz, 2H, 2CHAr), 7.38–7.35 (m, 8H, 8CHAr), 7.33–7.27 (m, 6H, 6CHAr), 2.40 (s, 3H, CH3). 13C{1H} NMR (175 MHz, CDCl3): δ [ppm] 145.5 (CAr), 141.3 (4CAr), 137.8 (2CAr), 135.2 (CAr), 134.1 (2CAr), 130.1 (2CHAr), 127.2 (2CHAr), 127.1 (2CAr), 126.8 (2CHAr), 126.0 (4CHAr), 123.5 (4CAr), 120.4 (4CHAr), 120.1 (4CHAr), 119.1 (2CHAr), 116.4 (2CHAr), 109.5 (4CHAr), 21.6 (CH3). IR νmax cm–1: 1452 (s), 1228 (s), 748 (s). mp: 306–311 °C.

9′H-9,3′:6′,9″-Tercarbazole (1c)[56]

In a round-bottom flask, 9′-tosyl-9′H-9.3′:6′,9″-tercarbazole (13.5 mmol; 8.925 g) was dissolved in the mixture of THF (30 mL), DMSO (15 mL), and water (5 mL) and stirred for 10 min. Then, KOH (164 mmol; 9.20 g) was added. The reaction was stirred for 18 h under reflux. After this time, the reaction was cooled to room temperature, and H2O (15 mL) was added, followed by neutralization with aqueous HCl (2 M). The resulting precipitate was filtered off; then washed with H2O (50 mL), MeOH (2 × 100 mL), and Et2O (50 mL); and dried to obtain the product as a gray solid (6.039 g, 90%). 1H NMR (CDCl3, 700 MHz): δ [ppm] 8.57 (s, 1H, NH), 8.20 (d, J = 1.8 Hz, 2H, 2CHAr), 8.16 (d, J = 7.8 Hz, 4H, 4CHAr), 7.71 (d, J = 8.7 Hz, 2H, 2CHAr), 7.62 (dd, J = 8.9, 2.1 Hz, 2H, 2CHAr), 7.41–7.36 (m, 8H, 8CHAr), 7.29–7.26 (m, 4H, 4CHAr). 13C{1H} NMR (175 MHz, CDCl3): δ [ppm] 141.9 (4CAr), 139.3 (2CHAr), 130.1 (2CAr), 126.1 (2CHAr), 125.9 (4CHAr), 124.2 (2CAr), 123.2 (4CAr), 120.3 (4CHAr), 119.8 (2CHAr), 119.7 (4CHAr), 112.0 (2CHAr), 109.7 (4CHAr). IR νmax cm–1: 1452 (s), 1232 (s), 748 (s). mp: 330–333 °C.

9′,9‴′,9‴‴′,9‴‴‴′-((4,8-Didecylbenzo[1,2-b:4,5-b′]difuran-2,3,6,7-tetrayl)tetrakis(benzene-4,1-diyl))tetrakis(9′H-9,3′:6′,9″-tercarbazole) (2h)

This compound was prepared according to the procedure for 2a except TBBDF (0.15 mmol; 158 mg), tercarbazole (0.9 mmol; 447 mg), [Pd(allyl)Cl]2 (0.012 mmol; 4.5 mg; 8 mol %), t-BuXPhos (0.048 mmol; 20.4 mg; 32 mol %), and t-BuOLi (1 M, 0.9 mmol; 0.9 mL). After 72 h, the reaction mixture was cooled to RT and transferred into a separatory funnel. Chloroform (20 mL) and water (50 mL) were added, and the layers were separated. The aqueous layer was extracted with chloroform (3 × 20 mL). Combined organic layers were dried over anhydrous magnesium sulfate and concentrated. The crude product was stirred in chloroform (5 mL), and then MeOH (20 mL) was added. The precipitate formed was filtered off and dried under vacuum. Purification by flash, DCM/PE 1:1, afforded 233 mg (57%) of yellow powder. 1H NMR (CDCl3, 700 MHz): δ [ppm] 8.39–8.37 (m, 4H, 4CHAr), 8.31–8.29 (m, 4H, 4CHAr), 8.21–8.17 (m, 16H, 16CHAr), 8.12–8.06 (m, 12H, 12CHAr), 7.91–7.87 (m, 4H, 4CHAr), 7.84–7.82 (m, 4H, 4CHAr), 7.77–7.73 (m, 8H, 8CHAr), 7.66–7.63 (m, 4H, 4CHAr), 7.46–7.42 (m, 18H, 18CHAr), 7.40–7.38 (m, 14H, 14CHAr), 7.33–7.28 (m, 16H, 16CHAr), 3.13–3.04 (m, 4H, 2CH2), 1.87–1.76 (m, 4H, 2CH2), 1.35–1.08 (m, 28H, 14CH2), 0.72 (t, J = 7.2 Hz, 6H, 2CH3). 13C{1H} NMR (175 MHz, CDCl3): δ [ppm] 150.3 (2CAr), 150.2 (2CAr), 141.8 (8CAr), 141.8 (8CAr), 140.5 (4CAr), 140.5 (4CAr), 137.5 (2CAr), 137.0 (2CAr), 134.7 (2CAr), 132.8 (4CHAr), 131.0 (4CAr), 130.8 (4CAr), 130.7 (2CAr), 128.1 (4CHAr), 127.8 (4CHAr), 127.2 (4CHAr), 126.5 (4CHAr), 126.3 (4CHAr), 125.9 (8CHAr), 125.9 (8CHAr), 125.9 (4CHAr), 124.4 (4CAr), 124.3 (4CAr), 123.3 (8CAr), 123.3 (8CAr), 123.2 (2CAr), 120.4 (8CHAr), 120.3 (8CHAr), 120.3 (4CHAr), 120.0 (4CHAr), 119.9 (4CHAr), 119.8 (8CHAr), 119.8 (8CHAr), 118.6 (2CAr), 116.6 (2CAr), 111.3 (4CHAr), 111.1 (4CHAr), 109.6 (8CHAr), 31.8 (2CH3), 31.2 (2CH2), 30.4 (2CH2), 29.7 (2CH2), 29.7 (2CH2), 29.6 (2CH2), 29.3 (2CH2), 26.0 (2CH2), 22.5 (2CH2), 13.9 (2CH3). IR νmax cm–1: 1454 (s), 1226 (s), 744 (s). mp: 276–281 °C. Anal. Calcd for C198H146N12O2: C, 87.26; H, 5.40; N, 6.17; O, 1.17. Found: C, 87.61; H, 5.43; N, 6.27; O, 1.14.

tert-Butyl 3,6-Bis(diphenylamino)-9H-carbazole-9-carboxylate[57]

In a 10 mL vial, Pd2(dba)3 (0.048 mmol; 44 mg; 2 mol %) and XPhos (0.192 mmol; 91.6 mg; 8 mol %) were mixed in dry, degassed toluene (5 mL) and stirred for 5 min in an inert gas atmosphere. In a round-bottom flask, diphenylamine (5 mmol; 0.845 g) was dissolved in dry, degassed toluene (10 mL), t-BuONa (5 mmol; 0.480 mL) was added, and the mixture was stirred for 5 min under argon. tert-Butyl-3,6-dibromo-9H-carbazole-9-carboxylate (2.4 mmol; 1.02 g) was added, followed by the catalyst mixture. The flask was immersed in an oil bath preheated to 100 °C and stirred at this temperature for 24 h. Then, the reaction mixture was cooled to RT and transferred into a separatory funnel. DCM (10 mL) and water (20 mL) were added, and the layers were separated. The aqueous layer was extracted with DCM (3 × 20 mL). Combined organic layers were dried over anhydrous magnesium sulfate and concentrated. The crude product was stirred in MeOH (50 mL) at 65 °C for 0.5 h, and the solid phase was filtered off and dried to obtain the product as a yellow solid, 1.14 g (79%). 1H NMR (DMSO-d6, 700 MHz): δ [ppm] 8.19 (d, J = 8.9 Hz, 2H, 2CHAr), 7.83 (d, J = 2.5 Hz, 2H, 2CHAr), 7.26–7.21 (m, 10H, 10CHAr), 6.98–6.94 (m, 12H, 12CHAr), 1.69 (s, 9H, 3CH3). 13C{1H} NMR (175 MHz, DMSO-d6): δ [ppm] 150.6 (C), 148.1 (2CAr), 143.3 (CAr), 135.4 (CAr), 129.8 (8CHAr), 129.6 (4CHAr), 126.6 (2CHAr), 126.6 (2CAr), 123.1 (8CHAr), 122.7 (4CHAr), 118.0 (2CHAr), 117.6 (2CHAr), 84.7 (C), 28.3 (3CH3). IR νmax cm–1: 1478 (s), 1214 (s), 749 (s). mp: 131–132 °C.

N3,N3,N6,N6-Tetraphenyl-9H-carbazole-3,6-diamine (1d)[57]

tert-Butyl-3,6-bis(diphenylamino)-9H-carbazole-9-carboxylate (1.66 mmol; 1 g) was dissolved in DCM (10 mL). Trifluoroacetic acid (16.6 mmol; 1.9 g) was added dropwise to the mixture and stirred at RT for 2.5 h. Then, DCM (50 mL) was added to the reaction mixture, and the organic layer was washed with saturated aqueous NaHCO3 solution and dried over MgSO4. The solvent was evaporated to afford 0.681 g of a green solid (82%). 1H NMR (DMSO-d6, 700 MHz): δ [ppm] 11.37 (s, 1H, NH), 7.88 (d, J = 2.2 Hz, 2H, 2CHAr), 7.50 (d, J = 8.9 Hz, 2H, 2CHAr), 7.23–7.19 (m, 8H, 8CHAr), 7.17 (dd, J = 8.6, 2.1 Hz, 2H, 2CHAr), 6.96–6.93 (m, 8H, 8CHAr), 6.90 (t, J = 7.4 Hz, 4H, 4CHAr). 13C{1H} NMR (175 MHz, DMSO-d6): δ [ppm] 148.7 (4CAr), 138.9 (2CAr), 138.5 (2CAr), 129.6 (8CHAr), 126.5 (2CHAr), 123.9 (2CAr), 122.3 (8CHAr), 121.8 (4CHAr), 119.8 (2CHAr), 112.8 (2CHAr). IR νmax cm–1: 1476 (s), 1230 (s), 748 (s). mp: 246–248 °C.

9,9′,9″,9‴-((4,8-Didecylbenzo[1,2-b:4,5-b′]difuran-2,3,6,7-tetrayl)tetrakis(benzene-4,1-diyl))tetrakis(N3,N3,N6,N6-tetraphenyl-9H-carbazole-3,6-diamine) (2i)

This compound was prepared according to the procedure for 2h except N3,N3,N6,N6-tetraphenyl-9H-carbazole-3,6-diamine (0.9 mmol, 451 mg) and t-BuONa (0.9 mmol, 86 mg), and the reaction was performed at 170 °C in a sealed tube. The reaction was cooled to room temperature and poured into MeOH (50 mL). The precipitated solid was filtered on a glass Büchner funnel, washed with MeOH (30 mL), and air-dried. Purification by flash chromatography, DCM/PE 2:3, afforded 193 mg (43%) of yellow powder. 1H NMR (CDCl3, 700 MHz): δ [ppm] 7.91–7.83 (m, 16H, 16CHAr), 7.79–7.75 (m, 4H, 4CHAr), 7.61–7.57 (m, 4H, 4CHAr), 7.52–7.49 (m, 4H, 4CHAr), 7.41–7.38 (m, 4H, 4CHAr), 7.31–7.29 (m, 4H, 4CHAr), 7.26–7.20 (m, 36H, 36CHAr), 7.14–7.06 (m, 32H, 32CHAr), 6.99–6.93 (m, 16H, 16CHAr), 2.96–2.91 (m, 4H, 2CH2), 1.68–1.63 (m, 4H, 2CH2), 1.29–1.14 (m, 28H, 14CH2), 0.78 (t, J = 7.2 Hz, 6H, 2CH3). 13C{1H} NMR (175 MHz, CDCl3): δ [ppm] 150.2 (2CAr), 150.0 (2CAr), 148.5 (8CAr), 148.5 (8CAr), 140.9 (4CAr), 140.8 (4CAr), 138.2 (4CAr), 138.1 (4CAr), 137.7 (2CAr), 137.3 (2CAr), 133.7 (2CAr), 132.4 (4CHAr), 129.8 (2CAr), 129.1 (16CHAr), 129.1 (16CHAr), 127.7 (4CHAr), 127.3 (4CHAr), 126.6 (4CHAr), 126.1 (2CAr), 126.0 (4CHAr), 125.9 (4CHAr), 124.4 (4CAr), 124.3 (4CAr), 122.8 (16CHAr), 122.8 (16CHAr), 121.8 (8CHAr), 121.7 (8CHAr), 118.7 (4CHAr), 118.6 (4CHAr), 118.3 (2CAr), 116.3 (2CAr), 110.9 (4CHAr), 110.7 (4CHAr), 31.8 (2CH2), 31.2 (2CH2), 30.2 (2CH2), 29.6 (2CH2), 29.6 (2CH2), 29.5 (2CH2), 29.2 (2CH2), 25.9 (2CH2), 22.6 (2CH2), 14.1 (2CH3). IR νmax cm–1: 1486 (s), 1224 (m), 749 (s). mp: 156–157 °C. Anal. Calcd for C198H162N12O2: C, 86.75; H, 5.96; N, 6.13; O, 1.17. Found: C, 86.44; H, 6.04; N, 6.16; O, 1.11.

4′,4‴,4‴″,4‴‴′-(4,8-Didecylbenzo[1,2-b:4,5-b′]difuran-2,3,6,7-tetrayl)tetrakis(N,N-diphenyl-[1,1′-biphenyl]-4-amine) (2j)

In a Schlenk tube, TBBDF (0.5 mmol; 527 mg), 4-(diphenylamino)phenylboronic acid pinacol ester (2.5 mmol; 927 mg), and Pd(dppf)Cl2·DCM (0.01 mmol; 8.17 mg; 2 mol %) were mixed in degassed 1,4-dioxane (5 mL) and stirred under argon for 5 min. 3 M K3PO4 (1 mL) was added, and the mixture was immersed in an oil bath preheated to 100 °C and stirred overnight. It was cooled to RT and poured into MeOH (20 mL), and the precipitate formed was filtered off and dried under vacuum. Purification by flash chromatography, DCM/PE 1:1, afforded 773 mg (90%) of green powder. 1H NMR (CDCl3, 700 MHz): δ [ppm] 7.75 (d, J = 8.2 Hz, 4H, 4CHAr), 7.64 (d, J = 8.6 Hz, 4H, 4CHAr), 7.59 (t, J = 8.7 Hz, 8H, 8CHAr), 7.47 (d, J = 8.6 Hz, 4H, 4CHAr), 7.44 (d, J = 8.7 Hz, 4H, 4CHAr), 7.31–7.27 (m, 8H, 8CHAr), 7.27–7.23 (m, 8H, 8CHAr), 7.21 (d, J = 8.5 Hz, 4H, 4CHAr), 7.17 (dd, J = 8.6, 1.2 Hz, 8H, 8CHAr), 7.12 (dd, J = 8.7, 0.8 Hz, 8H, 8CHAr), 7.10 (d, J = 8.6 Hz, 4H, 4CHAr), 7.06 (tt, J = 7.4, 1.0 Hz, 4H, 4CHAr), 7.03 (tt, J = 7.9, 1.0 Hz, 4H, 4CHAr), 2.81–2.72 (m, 4H, 2CH2), 1.52–1.47 (m, 4H, 2CH2), 1.27–1.10 (m, 28H, 14CH2), 0.82 (t, J = 7.2 Hz, 6H, 2CH3). 13C{1H} NMR (175 MHz, CDCl3): δ [ppm] 149.9 (2CAr), 147.7 (8CAr), 147.6 (4CAr), 147.5 (2CAr), 147.4 (2CAr), 140.0 (2CAr), 134.6 (2CAr), 134.2 (2CAr), 131.3 (4CHAr), 131.2 (2CAr), 129.3 (8CHAr), 129.3 (8CHAr), 127.7 (4CHAr), 127.4 (4CHAr), 126.9 (4CHAr), 126.7 (4CHAr), 126.3 (4CHAr), 126.0 (2CAr), 124.5 (8CAr), 124.5 (8CHAr), 124.0 (4CHAr), 123.7 (4CHAr), 123.0 (8CHAr), 118.4 (2CAr), 118.4 (2CAr), 116.1 (2CAr), 31.9 (2CH2), 31.0 (2CH2), 29.9(2CH2), 29.6 (2CH2), 29.6 (2CH2), 29.4 (4CH2), 25.6 (2CH2), 22.7 (2CH2), 14.1 (2CH3). IR νmax cm–1: 1486 (s), 1274 (m), 749 (m). mp: 261–262 °C. Anal. Calcd for C126H114N4O2: C, 88.18; H, 6.70; N, 3.26; O, 1.86. Found: C, 87.94; H, 6.67; N, 3.23; O, 1.90.
  27 in total

1.  Multiwfn: a multifunctional wavefunction analyzer.

Authors:  Tian Lu; Feiwu Chen
Journal:  J Comput Chem       Date:  2011-12-08       Impact factor: 3.376

2.  Versatile strategy to access fully functionalized benzodifurans: redox-active chromophores for the construction of extended pi-conjugated materials.

Authors:  Chenyi Yi; Carmen Blum; Mario Lehmann; Stephan Keller; Shi-Xia Liu; Gabriela Frei; Antonia Neels; Jürg Hauser; Stefan Schürch; Silvio Decurtins
Journal:  J Org Chem       Date:  2010-05-21       Impact factor: 4.354

3.  Organic host materials for phosphorescent organic light-emitting diodes.

Authors:  Youtian Tao; Chuluo Yang; Jingui Qin
Journal:  Chem Soc Rev       Date:  2011-03-03       Impact factor: 54.564

4.  Bis(carbazolyl)benzodifuran has a high triplet energy level for application in blue phosphorescent OLED.

Authors:  Chikahiko Mitsui; Hideyuki Tanaka; Hayato Tsuji; Eiichi Nakamura
Journal:  Chem Asian J       Date:  2011-07-11

5.  GFN2-xTB-An Accurate and Broadly Parametrized Self-Consistent Tight-Binding Quantum Chemical Method with Multipole Electrostatics and Density-Dependent Dispersion Contributions.

Authors:  Christoph Bannwarth; Sebastian Ehlert; Stefan Grimme
Journal:  J Chem Theory Comput       Date:  2019-02-11       Impact factor: 6.006

Review 6.  The Buchwald-Hartwig Amination After 25 Years.

Authors:  Ruth Dorel; Christian P Grugel; Alexander M Haydl
Journal:  Angew Chem Int Ed Engl       Date:  2019-09-18       Impact factor: 15.336

7.  Design and Functions of Semiconducting Fused Polycyclic Furans for Optoelectronic Applications.

Authors:  Hayato Tsuji; Eiichi Nakamura
Journal:  Acc Chem Res       Date:  2017-02-06       Impact factor: 22.384

8.  Synthesis, structures, redox and photophysical properties of benzodifuran-functionalised pyrene and anthracene fluorophores.

Authors:  Stephan Keller; Chenyi Yi; Chen Li; Shi-Xia Liu; Carmen Blum; Gabriela Frei; Olha Sereda; Antonia Neels; Thomas Wandlowski; Silvio Decurtins
Journal:  Org Biomol Chem       Date:  2011-07-26       Impact factor: 3.876

9.  Synthesis and redox and photophysical properties of benzodifuran-spiropyran ensembles.

Authors:  Hui Li; Jie Ding; Songjie Chen; Christoph Beyer; Shi-Xia Liu; Hans-Achim Wagenknecht; Andreas Hauser; Silvio Decurtins
Journal:  Chemistry       Date:  2013-03-13       Impact factor: 5.236

10.  Unravelling the electron injection/transport mechanism in organic light-emitting diodes.

Authors:  Tsubasa Sasaki; Munehiro Hasegawa; Kaito Inagaki; Hirokazu Ito; Kazuma Suzuki; Taku Oono; Katsuyuki Morii; Takahisa Shimizu; Hirohiko Fukagawa
Journal:  Nat Commun       Date:  2021-05-11       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.